Review



elisa reagent diluent concentration 2  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    R&D Systems elisa reagent diluent concentration 2
    Elisa Reagent Diluent Concentration 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 155 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/elisa+reagent+diluent+concentration+2/Reagent+Diluent+Concentrate+2/10__1016_slash_j__sbsr__2024__100725-73-43-48
    Average 95 stars, based on 155 article reviews
    elisa reagent diluent concentration 2 - by Bioz Stars, 2026-10
    95/100 stars

    Images

    Related Articles

    Enzyme-linked Immunosorbent Assay:

    Article Title: Cost-effective Amperometric Immunosensor for cardiac troponin I as a step towards affordable point-of-care diagnosis of acute myocardial infarction
    Article Snippet: .. Cardiac troponin I ELISA kit (R&D systems, cat number DY6887–05) containing Human Troponin I Capture antibody (Part #844233), Human Troponin I Detection antibody (Part #844234), Human Troponin I Standard (Part #844235), Streptavidin-HRP B (Part #83975), Wash buffer 25 x concentrate (R&D Systems, WA126), ELISA Reagent diluent concentration 2 (R&D Systems, DY995), R&D systems matrix metalloproteinase-3 (MMP3) ELISA kit (R&D Systems, Cat. No. DY513), TMB Substrate Solution 1:1 mixture of Colour Reagent A (H2O2) and Colour Reagent B (Tetramethylbenzidine (TMB) (R&D Systems, Cat. No. DY999), H2SO4 (Sigma), Potassium Ferricyanide (Sigma), PBS (Sigma), 96-well plates (Sigma). cTnI depleted Human serum (Hytest, Cat. #8TFS2), C-reactive protein (CRP) (R&D Systems, DY1707), IL-6 (R&D systems, DY206), TNFα (R&D systems, DY210). .. All other reagents, including Phosphate-Buffered Saline (PBS) tablets, Bovine Serum Albumin (BSA) Solution (A7906), 1,4-dithiothreitol (DTT), 6-Mercapto-1-hexanol (MCH), and Sulfo-LC-SPDP (#803316) were purchased from Sigma Aldrich (UK).

    Concentration Assay:

    Article Title: Cost-effective Amperometric Immunosensor for cardiac troponin I as a step towards affordable point-of-care diagnosis of acute myocardial infarction
    Article Snippet: .. Cardiac troponin I ELISA kit (R&D systems, cat number DY6887–05) containing Human Troponin I Capture antibody (Part #844233), Human Troponin I Detection antibody (Part #844234), Human Troponin I Standard (Part #844235), Streptavidin-HRP B (Part #83975), Wash buffer 25 x concentrate (R&D Systems, WA126), ELISA Reagent diluent concentration 2 (R&D Systems, DY995), R&D systems matrix metalloproteinase-3 (MMP3) ELISA kit (R&D Systems, Cat. No. DY513), TMB Substrate Solution 1:1 mixture of Colour Reagent A (H2O2) and Colour Reagent B (Tetramethylbenzidine (TMB) (R&D Systems, Cat. No. DY999), H2SO4 (Sigma), Potassium Ferricyanide (Sigma), PBS (Sigma), 96-well plates (Sigma). cTnI depleted Human serum (Hytest, Cat. #8TFS2), C-reactive protein (CRP) (R&D Systems, DY1707), IL-6 (R&D systems, DY206), TNFα (R&D systems, DY210). .. All other reagents, including Phosphate-Buffered Saline (PBS) tablets, Bovine Serum Albumin (BSA) Solution (A7906), 1,4-dithiothreitol (DTT), 6-Mercapto-1-hexanol (MCH), and Sulfo-LC-SPDP (#803316) were purchased from Sigma Aldrich (UK).



    Similar Products

    95
    R&D Systems elisa reagent diluent concentration 2
    Elisa Reagent Diluent Concentration 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/elisa+reagent+diluent+concentration+2/Reagent+Diluent+Concentrate+2/10__1016_slash_j__sbsr__2024__100725-73-43-48
    Average 95 stars, based on 1 article reviews
    elisa reagent diluent concentration 2 - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    95
    R&D Systems bsa elisa reagent diluent blocking solution concentrate
    In vitro validation data (A) hBMP2 <t>ELISA</t> data from HEK293T cells. All computationally selected sequences showed non-significant increases in secretion. N = 7 ± SD, **** = p < 0.0001 (B) hBMP2 ELISA data from C2C12 cells. All computationally selected sequences showed decreased secretion versus the positive control, with several showing significant decreases. Particularly notable were the sequences that showed major decreases in the C2C12 results compared to the HEK293T experiment. These were SP1, SP2, SP hIL2 and SP hBMP2 TIS. N = 3 ± SD. * = p < 0.05, ** = p < 0.01, *** = p < 0.001 C) ALP assay data from C2C12 cells. All groups except the positive control showed background levels of ALP activity, indicating the novel SPs were not sufficient to induce osteogenesis in this context. N = 3 ± SD, *** = p < 0.001
    Bsa Elisa Reagent Diluent Blocking Solution Concentrate, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/elisa+reagent+diluent+concentration+2/Reagent+Diluent+Concentrate+2/pmc11112908-98-7-14
    Average 95 stars, based on 1 article reviews
    bsa elisa reagent diluent blocking solution concentrate - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    95
    R&D Systems elisa reactants
    In vitro validation data (A) hBMP2 <t>ELISA</t> data from HEK293T cells. All computationally selected sequences showed non-significant increases in secretion. N = 7 ± SD, **** = p < 0.0001 (B) hBMP2 ELISA data from C2C12 cells. All computationally selected sequences showed decreased secretion versus the positive control, with several showing significant decreases. Particularly notable were the sequences that showed major decreases in the C2C12 results compared to the HEK293T experiment. These were SP1, SP2, SP hIL2 and SP hBMP2 TIS. N = 3 ± SD. * = p < 0.05, ** = p < 0.01, *** = p < 0.001 C) ALP assay data from C2C12 cells. All groups except the positive control showed background levels of ALP activity, indicating the novel SPs were not sufficient to induce osteogenesis in this context. N = 3 ± SD, *** = p < 0.001
    Elisa Reactants, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/elisa+reagent+diluent+concentration+2/Reagent+Diluent+Concentrate+2/pm38203183-378-6-25
    Average 95 stars, based on 1 article reviews
    elisa reactants - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    95
    R&D Systems elisa diluent r d systems cat
    In vitro validation data (A) hBMP2 <t>ELISA</t> data from HEK293T cells. All computationally selected sequences showed non-significant increases in secretion. N = 7 ± SD, **** = p < 0.0001 (B) hBMP2 ELISA data from C2C12 cells. All computationally selected sequences showed decreased secretion versus the positive control, with several showing significant decreases. Particularly notable were the sequences that showed major decreases in the C2C12 results compared to the HEK293T experiment. These were SP1, SP2, SP hIL2 and SP hBMP2 TIS. N = 3 ± SD. * = p < 0.05, ** = p < 0.01, *** = p < 0.001 C) ALP assay data from C2C12 cells. All groups except the positive control showed background levels of ALP activity, indicating the novel SPs were not sufficient to induce osteogenesis in this context. N = 3 ± SD, *** = p < 0.001
    Elisa Diluent R D Systems Cat, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/elisa+reagent+diluent+concentration+2/Reagent+Diluent+Concentrate+2/pm37598339-205-65-67
    Average 95 stars, based on 1 article reviews
    elisa diluent r d systems cat - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    95
    R&D Systems elisa plates
    In vitro validation data (A) hBMP2 <t>ELISA</t> data from HEK293T cells. All computationally selected sequences showed non-significant increases in secretion. N = 7 ± SD, **** = p < 0.0001 (B) hBMP2 ELISA data from C2C12 cells. All computationally selected sequences showed decreased secretion versus the positive control, with several showing significant decreases. Particularly notable were the sequences that showed major decreases in the C2C12 results compared to the HEK293T experiment. These were SP1, SP2, SP hIL2 and SP hBMP2 TIS. N = 3 ± SD. * = p < 0.05, ** = p < 0.01, *** = p < 0.001 C) ALP assay data from C2C12 cells. All groups except the positive control showed background levels of ALP activity, indicating the novel SPs were not sufficient to induce osteogenesis in this context. N = 3 ± SD, *** = p < 0.001
    Elisa Plates, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/elisa+reagent+diluent+concentration+2/Reagent+Diluent+Concentrate+2/pmc06487088-65-0-5
    Average 95 stars, based on 1 article reviews
    elisa plates - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    95
    R&D Systems elisa kits
    In vitro validation data (A) hBMP2 <t>ELISA</t> data from HEK293T cells. All computationally selected sequences showed non-significant increases in secretion. N = 7 ± SD, **** = p < 0.0001 (B) hBMP2 ELISA data from C2C12 cells. All computationally selected sequences showed decreased secretion versus the positive control, with several showing significant decreases. Particularly notable were the sequences that showed major decreases in the C2C12 results compared to the HEK293T experiment. These were SP1, SP2, SP hIL2 and SP hBMP2 TIS. N = 3 ± SD. * = p < 0.05, ** = p < 0.01, *** = p < 0.001 C) ALP assay data from C2C12 cells. All groups except the positive control showed background levels of ALP activity, indicating the novel SPs were not sufficient to induce osteogenesis in this context. N = 3 ± SD, *** = p < 0.001
    Elisa Kits, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/elisa+reagent+diluent+concentration+2/Reagent+Diluent+Concentrate+2/pmc06682179-38-14-25
    Average 95 stars, based on 1 article reviews
    elisa kits - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    96
    R&D Systems elisa kit
    In vitro validation data (A) hBMP2 <t>ELISA</t> data from HEK293T cells. All computationally selected sequences showed non-significant increases in secretion. N = 7 ± SD, **** = p < 0.0001 (B) hBMP2 ELISA data from C2C12 cells. All computationally selected sequences showed decreased secretion versus the positive control, with several showing significant decreases. Particularly notable were the sequences that showed major decreases in the C2C12 results compared to the HEK293T experiment. These were SP1, SP2, SP hIL2 and SP hBMP2 TIS. N = 3 ± SD. * = p < 0.05, ** = p < 0.01, *** = p < 0.001 C) ALP assay data from C2C12 cells. All groups except the positive control showed background levels of ALP activity, indicating the novel SPs were not sufficient to induce osteogenesis in this context. N = 3 ± SD, *** = p < 0.001
    Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/elisa+reagent+diluent+concentration+2/Reagent+Diluent+Concentrate+2/pm28259830-102-21-24
    Average 96 stars, based on 1 article reviews
    elisa kit - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    Image Search Results


    In vitro validation data (A) hBMP2 ELISA data from HEK293T cells. All computationally selected sequences showed non-significant increases in secretion. N = 7 ± SD, **** = p < 0.0001 (B) hBMP2 ELISA data from C2C12 cells. All computationally selected sequences showed decreased secretion versus the positive control, with several showing significant decreases. Particularly notable were the sequences that showed major decreases in the C2C12 results compared to the HEK293T experiment. These were SP1, SP2, SP hIL2 and SP hBMP2 TIS. N = 3 ± SD. * = p < 0.05, ** = p < 0.01, *** = p < 0.001 C) ALP assay data from C2C12 cells. All groups except the positive control showed background levels of ALP activity, indicating the novel SPs were not sufficient to induce osteogenesis in this context. N = 3 ± SD, *** = p < 0.001

    Journal: BMC Biotechnology

    Article Title: A new mRNA structure prediction based approach to identifying improved signal peptides for bone morphogenetic protein 2

    doi: 10.1186/s12896-024-00858-1

    Figure Lengend Snippet: In vitro validation data (A) hBMP2 ELISA data from HEK293T cells. All computationally selected sequences showed non-significant increases in secretion. N = 7 ± SD, **** = p < 0.0001 (B) hBMP2 ELISA data from C2C12 cells. All computationally selected sequences showed decreased secretion versus the positive control, with several showing significant decreases. Particularly notable were the sequences that showed major decreases in the C2C12 results compared to the HEK293T experiment. These were SP1, SP2, SP hIL2 and SP hBMP2 TIS. N = 3 ± SD. * = p < 0.05, ** = p < 0.01, *** = p < 0.001 C) ALP assay data from C2C12 cells. All groups except the positive control showed background levels of ALP activity, indicating the novel SPs were not sufficient to induce osteogenesis in this context. N = 3 ± SD, *** = p < 0.001

    Article Snippet: Nunc MaxiSorp ELISA plates (M9410, Merck), 10% BSA ELISA reagent diluent/blocking solution concentrate (DY995, R&D systems) and TMB substrate (421,501, Biolegend) were purchased separately and used for all experiments.

    Techniques: In Vitro, Biomarker Discovery, Enzyme-linked Immunosorbent Assay, Positive Control, ALP Assay, Activity Assay

    Linear regression analyses of the SP score values and ELISA data ( A ) ELISA data from the HEK239T experiment. Correlation was found to be significant (gradient = 0.0509, R2 = 0.096, F [ , ] = 4.976, p = 0.0305) ( B ) ELISA data from the C2C12 experiment. No significant correlation was found (gradient = 0.0427, R2 = 0.138, F [ , ] = 3.038, p = 0.0975)

    Journal: BMC Biotechnology

    Article Title: A new mRNA structure prediction based approach to identifying improved signal peptides for bone morphogenetic protein 2

    doi: 10.1186/s12896-024-00858-1

    Figure Lengend Snippet: Linear regression analyses of the SP score values and ELISA data ( A ) ELISA data from the HEK239T experiment. Correlation was found to be significant (gradient = 0.0509, R2 = 0.096, F [ , ] = 4.976, p = 0.0305) ( B ) ELISA data from the C2C12 experiment. No significant correlation was found (gradient = 0.0427, R2 = 0.138, F [ , ] = 3.038, p = 0.0975)

    Article Snippet: Nunc MaxiSorp ELISA plates (M9410, Merck), 10% BSA ELISA reagent diluent/blocking solution concentrate (DY995, R&D systems) and TMB substrate (421,501, Biolegend) were purchased separately and used for all experiments.

    Techniques: Enzyme-linked Immunosorbent Assay